Searched for
SUBCUTANEOUS FORMULATION
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drugThe US FDA approved an at-home starting dose for Eisai and Biogen's Alzheimer's drug. This new subcutaneous formulation allows patients to ...- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancerRoche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...
- Show of hands: Handcare has become the next big thing in skincare in the West. India is catching upA viral 15-step handcare routine by influencer Victoria Ortega has helped fuel a growing global focus on handcare, turning hands into a new...
- Dr. Reddy’s Lab launches India’s first DCGI-approved Semaglutide injection for Type 2 DiabetesDr. Reddy's Laboratories has launched Obeda, a generic semaglutide injection for Type 2 diabetes, becoming the first Indian company to rece...
- Jazz Pharma, Roche's combination therapy for lung cancer gets US approvalThe FDA has approved Jazz Pharmaceuticals' Zepzelca and Roche's Tecentriq combination as the first and only first-line maintenance treatmen...
- Biocon shares rise 2% after USFDA approval for osteoporosis and bone loss drugsShares of Biocon Ltd rose 2% to Rs 361.25 on the BSE after its subsidiary, Biocon Biologics, received U.S. FDA approval for two denosumab b...
- Dr Reddy's unit ties up with Shanghai Henlius BiotechDr Reddy's Laboratories has partnered with Shanghai Henlius Biotech to develop and commercialize HLX15, a biosimilar to the cancer drug Dar...
- Big chase for a cancer drug: The urgent need for affordable Keytruda alternativesKeytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In Ind...
- Dr Reddy's Lab completes Phase 1 study of proposed arthritis drugDr Reddy's Laboratories Ltd on Monday said it has successfully completed the Phase 1 study of its proposed biosimilar of Tocilizumab to be ...
- Roche Pharma launches drug to treat breast cancerPHESGO was first approved by the US FDA in June 2020 during the peak of the Covid pandemic, by the European Medicines Agency (EMA) in Decem...
- Allergy signs overlapping with Covid symptoms? Guide to fight stuffy noses & scratchy throatsYou cannot avoid pollen entirely, but there are ways to prevent symptoms.
- The 2-billion Vaccine Question: How realistic are estimates and what's the current status?The Centre’s plan for 2 billion doses of Covid-19 vaccines by year-end depends on a massive ramp-up of production as well as flawless trial...
- Dr Reddy's gets FDA nod for 'Tosymra' migraine nasal sprayThe drug maker said the audit of its API manufacturing plant at Miryalaguda in Telangana, by the US FDA, has been completed.
- MCX, Sun Pharma, PNB Housing and Strides Pharma among stocks in the newsHere's a look at the top stocks that may hog the limelight in today's session.
- Indo-Dutch collaboration for cost-effective vaccine deliveryNew Delhi, June 1 (IANS) Vaccine maker Serum Institute of India and Netherland-based research and development organisation for vaccine tech...
- Life-saving tips for all skin types during the ruthless summerYour skin needs effective protection from the sun's harmful UVA and UVB ultraviolet rays.
- Looking for global partner for psoriasis drug: Kiran Mazumdar Shaw, BioconThe plan is that the India drug will launched as an intravenous infusion and it has been indicated for psoriasis, says Kiran Mazumdar Shaw.
Load More
